Merck Submits COVID Treatment Pill for FDA Approval After Study Yields Promising Data

Merck Submits COVID Treatment Pill for FDA Approval After Study Yields Promising Data


Drug-maker Merck says it has developed a pill that can treat mild to moderate cases of COVID-19, and the company is asking federal regulators to allow it to be used.

On Monday, the company announced that it has submitted a request for an Emergency Use Authorization from the Food and Drug Administration for a drug it has called molnupiravir, according to a statement on the company’s website. The drug is an “oral antiviral medicine that can be taken at home shortly after diagnosis with COVID-19,” the company said.

The statement said the drug, developed through a partnership with Ridgeback Biotherapeutics, is designed to treat “mild-to-moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization.”

Trending: Is This Why They Don’t Want You To Know About Ivermectin?

The company said that according to its

Continue reading

You Might Like

 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Thanks for sharing!
Send this to a friend